Exploration of key clinical trial data and real-world evidence on dupilumab in asthma and COPD presented at the ERS and CHEST ...

Among seven new medicines recommended for approval by the EMA's human medicine advisory committee at its latest meeting is ...

GSK plc GSK announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) ...

Breathwork can ease stress and alter immune markers. Can it also prevent infections during the winter virus season?

Hospitalizations for bronchiectasis exacerbations are associated with poorer in-hospital outcomes than those for chronic obstructive pulmonary disease or asthma exacerbations.

The toxic haze that blanketed large parts of India in November didn’t just cloud the skies—it pushed sales of asthma and COPD medicines to their highest levels in three years.

GSK’s depemokimab, a long-acting biologic that’s key in the British pharma’s growth plan, has won an endorsement from ...

Major advancements in pulmonary fibrosis treatment and critical warnings regarding both indoor air quality and scientific ...

Discover how poorer air quality due to smoke from Canadian wildfires in 2023 led to worsening asthma symptoms in children in ...

New research from the University of Vermont reveals exposure to smoke from Canadian wildfires in the summer of 2023 led to ...

Chronic bronchitis affects nearly 10% of adults in low- and middle-income countries, with links to worse respiratory outcomes ...

GSK’s Nucala receives positive CHMP opinion for treatment of chronic obstructive pulmonary disease: London, UK Monday, December 15, 2025, 16:00 Hrs [IST] GSK plc announced that ...